To test this hypothesis, MYCN non-amplified pediatric neuroblastoma patients in TARGET dataset were divided into older patients with higher DST expression, older patients with lower DST expression, younger patients with higher DST expression and younger patients with lower DST expression four sub-groups. Here, MYCN is linked to neuroblastoma.